Clinical trial participation is the only lawful and medically supervised means of accessing retatrutide in the UK at present
Conclusion The emergence of GLP-1 receptor agonists transformed obesity treatment by providing revolutionary effectiveness at reducing obesity along with improving metabolic control
Zepbound is prescribed for adults who: have obesity (a body mass index [BMI] of 30 or higher), or have overweight (with a BMI of 27 or higher) and a weight-related health condition, such as type 2 diabetes, high blood pressure, heart disease, high cholesterol, or obstructive sleep apnea Doctors also prescribe it to treat moderate to severe obstructive sleep apnea in adults with obesity
Costs vary by dose, pharmacy, and insurance coverage
They help reduce inflammation, speed up healing, and prevent further damage to the skin